English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cytomegalovirus (CMV) infection is one of the most important infectious complications of transplantation. Monitoring CMV-specific CD8 T cell immunity is useful for predicting active CMV infection and for directing targeted antiviral therapy. In this study, we examined four basic parameters for validation of CMV-specific tetramer staining and peptide stimulation assays that cover five most frequent HLA class I alleles. We also examined the potential use of CMV-specific CD8 +  T cell numbers and functional and cytolytic responses in two autologous HSCT recipients treated for multiple myeloma. The coefficient of variation (CV %) of the precision within assays was 3.1−24% for HLA-tetramer staining, 2.5−47% for IFN-  γ  , and 3.4−59.7% for CD107a/b production upon peptide stimulation. The precision between assays was 5−26% for tetramer staining, 4−24% for IFN-  γ  , and 5−48% for CD107a/b. The limit of detection was 0.1−0.23 cells/  μ  L of blood for tetramer staining, 0−0.23 cell/  μ  L for IFN-  γ  , and 0.11−0.98 cells/  μ  L for CD107a/b. The assays were linear and specific. The reference interval with 95% confidence level was 0−18 cells/  μ  L for tetramer staining, 0−2 cells/  μ  L for IFN-  γ  , and 0–3 cells/  μ  L for CD107a/b. Our results provide acceptable measures of test performance for CMV immune competence assays for the characterization of CD8 +  T cell responses posttransplant measured in the absolute cell count per   μ  L of blood.

Validation of Cytomegalovirus Immune Competence Assays for the Characterization of CD8+T Cell Responses Posttransplant

Validation of Cytomegalovirus Immune Competence Assays for the Characterization of CD8⁺T Cell Responses Posttransplant